LINE-1 Methylation Status in Multiple Sclerosis Patients Is Associated with Changes in Folate Metabolism

Area of Science:

• Neuroscience
• Epigenetics
• Genetics

Background:

• Epigenetic dysregulation, including abnormal DNA methylation, is implicated in neurodegenerative diseases like multiple sclerosis (MS).
• Alterations in methylation patterns in MS may affect gene expression related to inflammation and myelin integrity.
• The potential reversibility of epigenetic changes warrants investigation into their mechanisms.

Purpose of the Study:

• To investigate LINE-1 retrotransposon methylation status in peripheral blood cells of MS patients and healthy controls.
• To explore the relationship between LINE-1 methylation, MS duration, disease type, and relevant biochemical factors.

Main Methods:

• Analysis of LINE-1 retrotransposon methylation levels in peripheral blood cells.
• Comparison between multiple sclerosis patients and healthy individuals.
• Correlation analysis with clinical data (MS duration, type) and biochemical markers (homocysteine, vitamin B9, MTHFR genotype).

Main Results:

• LINE-1 methylation decreased with age in healthy individuals.
• MS patients showed a positive correlation between LINE-1 methylation and MS duration.
• Progressive MS exhibited higher LINE-1 methylation than remitting MS.
• LINE-1 methylation variations were associated with homocysteine, vitamin B9 levels, and MTHFR C677T genotype.

Conclusions:

• LINE-1 methylation patterns are altered in MS and associated with disease progression.
• The MTHFR C677T polymorphism contributes to epigenetic alterations in MS.
• Folate metabolism disruptions may mediate hypermethylation in MS pathogenesis.